Igen Biolab Group
  • Home
  • About Us
  • Technology
  • Pipeline
  • Press
    • News
    • Press Releases
    • Events
    • Publications
  • Contact
  • English
    • Español
Select Page
An unhealthy microbiota helps breast cancer to expand

An unhealthy microbiota helps breast cancer to expand

by Igen BioLab Group | Jun 26, 2019 | News, Sin categoría

New research from the University of Virginia Cancer Center suggests that inflamed and unhealthy bowels cause breast cancer to become much more invasive and spread more quickly to other parts of the body. Melanie Rutkowski, PhD, of the Department of Microbiology,...

Microbes are savvy investors when contributing to the common good

by Igen BioLab Group | Jun 20, 2018 | Events, Sin categoría

A collaboration between the University of Bath and University College London has revealed that microbes act like shrewd economists when cooperating. When they find themselves in groups with mostly relatives they contribute heavily to cooperation, which benefits the...

The Gut Microbiome and Rheumatoid Arthritis: Understanding the Connection.

by Igen BioLab Group | Jun 16, 2018 | Sin categoría

Veena Taneja, PhD, associate professor of immunology in the Department of Immunology and Rheumatology at the Mayo Clinic in Rochester, Minnesota, discussed in this interview the latest insights about the association between the gut microbiome and Rheumatoid Arthritis....

How gut microbes are joining the fight against cancer

by Igen BioLab Group | Jun 12, 2018 | Sin categoría

The intestinal microbiome seems to influence in the functioning of some anti-cancer drugs. But, is science mature to perform this type of clinical trials? In recent decades, scientists have linked the composition of mycrobiota with dozens of diseases ranging from...

Gut microbial diversity is associated with lower arterial stiffness in women

by Igen BioLab Group | Jun 10, 2018 | Sin categoría

The level of diversity of the good bacteria; in our digestive systems has been found to be linked to a feature of cardiovascular disease (hardening of the arteries) in new research by experts at the University of Nottingham and King’s College London. Now for the first...

The microbiome, the guardian of the immune response

by Igen BioLab Group | Jun 8, 2018 | Sin categoría

University of Chicago Medicine researchers report that specific microbiome assemblages can boost the response rate to immunotherapy for patients being treated for advanced melanoma. Their study (”The Commensal Microbiome Is Associated with Anti–PD-1 Efficacy in...
« Older Entries

Recent Posts

  • Metagenomic Analyses Reveal Distinct Gut Microbiota Signature for Predicting the Neoadjuvant Chemotherapy Responsiveness in Breast Cancer Patients
  • Deciphering the Microbiome-Immunity-Cancer Axis
  • Targeting the gut and tumor microbiota in cancer
  • Healthy gut microbiome improves success of cancer treatment
  • Nasopharyngeal Microbiota as an early severity biomarker in COVID-19 hospitalised patients
  • Aviso legal
  • Política de Privacidad
  • Política de cookies
  • Facebook
  • Twitter
  • Instagram
  • RSS
Design by loComunicas

This website uses its own and third-party cookies in order to analyze the traffic generated for statistical purposes.

You can accept all cookies by clicking "Accept", reject all of them by clicking "Deny" or configure them by clicking "Settings".

For more information on how this site uses cookies and related technologies, you can read our Policy on Cookies

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly necessary cookies

Strictly necessary cookies must always be activated so that we can save your cookie settings preferences.

If you deactivate this cookie, we will not be able to save your preferences. This means that every time you visit this website you will have to activate or deactivate cookies again.

Third party cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, or the most popular pages.

Leaving this cookie active allows us to improve our website.

Please activate the strictly necessary cookies first so that we can save your preferences!

Cookies policy

More information about our cookie policy